Time | SIC | SAC | P-value | Day 1 | | | | Prevalence, % | 22.0 (92/419) | 31.5 (132/419) | <0.001 | AUC (95% CI) | 0.85 (0.81-0.88) | 0.83 (0.79-0.87) | 0.307 | Sensitivity, % | 83.67 | 89.80 | 0.250 | Specificity, % | 86.22 | 76.22 | <0.001 | PPV, % | 44.6 | 33.3 | 0.088 | NPV, % | 97.6 | 98.3 | 0.545 | Day 3 | | | | Prevalence, % | 14.1 (59/419) | 20.8 (87/419) | <0.001 | AUC (95% CI) | 0.84 (0.80-0.87) | 0.81 (0.77-0.85) | 0.097 | Sensitivity, % | 75.00 | 77.50 | 1.000 | Specificity, % | 92.16 | 84.86 | <0.001 | PPV, % | 50.8 | 35.6 | 0.067 | NPV, % | 97.2 | 97.2 | 0.957 | Day 7 | | | | Prevalence, % | 10.3 (42/409) | 14.4 (59/409) | <0.001 | AUC (95% CI) | 0.86 (0.82-0.90) | 0.89 (0.85-0.92) | 0.422 | Sensitivity, % | 80.00 | 90.00 | 0.500 | Specificity, % | 92.40 | 88.18 | <0.001 | PPV, % | 38.1 | 30.5 | 0.426 | NPV, % | 98.7 | 99.4 | 0.725 | Day 14 | | | | Prevalence, % | 5.7 (22/389) | 7.5 (29/389) | 0.016 | AUC (95% CI) | 0.93 (0.89-0.96) | 0.91 (0.87-0.95) | 0.007 | Sensitivity, % | 90.91 | 90.91 | 1.000 | Specificity, % | 94.69 | 91.59 | 0.016 | PPV, % | 45.5 | 34.5 | 0.128 | NPV, % | 99.5 | 99.5 | 0.539 |
|